Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Ossur Hf: Insider trading

Posted on: 30 Oct 17

Announcement Össur hf. No. 78/2017


Viðskipti með eigin bréf/transaction in own financial instruments



Össur hf.

Dagsetning viðskipta/Date of transaction:

30 October 2017

Kaup eða sala/Buy or Sell:


Tegund fjármálagernings/Type of instrument:


Fjöldi hluta/Number of shares:


Gengi/Verð pr. Hlut/Price:

DKK 29.43

Fjöldi hluta eftir viðskipti/Primary insider's holdings after the transaction:


Dagsetning lokauppgjörs/Date of settlement:

1 November 2017

Ástæður viðskipta/Reason for transaction:

The shares are delivered in relation to an acquisition of a small prosthetics manufacturer. The share price is DKK 29.43, the Company's average share price on Nasdaq Copenhagen in the last 20 trading days.


Last updated on: 31/10/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.